Current and Emerging Therapies for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia

Dear Colleagues,

It is with great pleasure that I invite you to submit your original work for inclusion in this Special Issue of the Journal of Clinical Medicine, titled “Current and Emerging Therapies for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia”.

Lower urinary tract symptoms related to benign prostatic obstruction afflict the majority of men over 50 and are associated with worsening of urinary, sexual function, and quality of life. Until recently, therapy was mainly pharmacological with varying degrees of success and questionable compliance, while surgical options were limited to the “gold standard” transurethral resection of the prostatic adenoma, literally irrespective of prostate size.

As new, minimally invasive, day case, surgical treatments have emerged, the game in LUTS/BPH is certainly changing as many patients who were unwilling to stay on long-term medication or withstand the sexual side effects of it will opt for minimally invasive therapies promising to better preserve sexual function providing equal, if not better, relief from symptoms.

On the other hand, the management of the large prostate is currently shifting toward anatomical enucleation of the prostate, using a variety of energy sources and techniques, offering a definitive and lasting solution to lower urinary tract obstruction with minimal morbidity even in the outpatient setting.

Last but not least, lower urinary tract symptoms are often a result of previous procedures for benign or malignant indications, as in the case of urethral strictures and bladder neck stenosis. This Special Issue will also focus on emerging techniques for the prevention and management of urethral stricture disease.

Dr. Petros Sountoulides
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.